204 related articles for article (PubMed ID: 21334567)
21. Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion).
Antshel KM; Aneja A; Strunge L; Peebles J; Fremont WP; Stallone K; Abdulsabur N; Higgins AM; Shprintzen RJ; Kates WR
J Autism Dev Disord; 2007 Oct; 37(9):1776-86. PubMed ID: 17180713
[TBL] [Abstract][Full Text] [Related]
22. Sex differences in cognitive functioning in velocardiofacial syndrome (VCFS).
Antshel KM; AbdulSabur N; Roizen N; Fremont W; Kates WR
Dev Neuropsychol; 2005; 28(3):849-69. PubMed ID: 16266252
[TBL] [Abstract][Full Text] [Related]
23. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome).
Kates WR; Krauss BR; Abdulsabur N; Colgan D; Antshel KM; Higgins AM; Shprintzen RJ
Neuropsychologia; 2007 Sep; 45(12):2863-73. PubMed ID: 17618656
[TBL] [Abstract][Full Text] [Related]
24. Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis.
Padula MC; Schaer M; Armando M; Sandini C; Zöller D; Scariati E; Schneider M; Eliez S
Psychol Med; 2018 Oct; 48(14):2375-2383. PubMed ID: 29338796
[TBL] [Abstract][Full Text] [Related]
25. High rates of schizophrenia in adults with velo-cardio-facial syndrome.
Murphy KC; Jones LA; Owen MJ
Arch Gen Psychiatry; 1999 Oct; 56(10):940-5. PubMed ID: 10530637
[TBL] [Abstract][Full Text] [Related]
26. Neurocognitive and familial moderators of psychiatric risk in velocardiofacial (22q11.2 deletion) syndrome: a longitudinal study.
Kates WR; Russo N; Wood WM; Antshel KM; Faraone SV; Fremont WP
Psychol Med; 2015 Jun; 45(8):1629-39. PubMed ID: 25394491
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
Radoeva PD; Fremont W; Antshel KM; Kates WR
Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
[TBL] [Abstract][Full Text] [Related]
28. Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study.
Antshel KM; Shprintzen R; Fremont W; Higgins AM; Faraone SV; Kates WR
J Am Acad Child Adolesc Psychiatry; 2010 Apr; 49(4):333-44. PubMed ID: 20410726
[TBL] [Abstract][Full Text] [Related]
29. Reduced fronto-temporal and limbic connectivity in the 22q11.2 deletion syndrome: vulnerability markers for developing schizophrenia?
Ottet MC; Schaer M; Cammoun L; Schneider M; Debbané M; Thiran JP; Eliez S
PLoS One; 2013; 8(3):e58429. PubMed ID: 23533586
[TBL] [Abstract][Full Text] [Related]
30. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
[TBL] [Abstract][Full Text] [Related]
31. Velocardiofacial syndrome: is there a neuropsychiatric phenotype?
Jolin EM; Weller EB; Weller RA
Curr Psychiatry Rep; 2006 Apr; 8(2):96-101. PubMed ID: 16539883
[TBL] [Abstract][Full Text] [Related]
32. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2).
Kates WR; Burnette CP; Bessette BA; Folley BS; Strunge L; Jabs EW; Pearlson GD
J Child Neurol; 2004 May; 19(5):337-42. PubMed ID: 15224707
[TBL] [Abstract][Full Text] [Related]
33. Annotation: velo-cardio-facial syndrome.
Murphy KC
J Child Psychol Psychiatry; 2005 Jun; 46(6):563-71. PubMed ID: 15877762
[TBL] [Abstract][Full Text] [Related]
34. Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report.
Carandang CG; Scholten MC
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):115-20. PubMed ID: 17343559
[TBL] [Abstract][Full Text] [Related]
35. Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus.
Chow EW; Ho A; Wei C; Voormolen EH; Crawley AP; Bassett AS
Am J Psychiatry; 2011 May; 168(5):522-9. PubMed ID: 21362743
[TBL] [Abstract][Full Text] [Related]
36. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
[TBL] [Abstract][Full Text] [Related]
37. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome.
Antshel KM; Fremont W; Roizen NJ; Shprintzen R; Higgins AM; Dhamoon A; Kates WR
J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):596-603. PubMed ID: 16670654
[TBL] [Abstract][Full Text] [Related]
38. [Time processing in the velo-cardio-facial syndrome (22q11) and its link with the caudate nucleus].
Gabriel Mounir D; Debbané M; Schaer M; Glaser B; Eliez S
Encephale; 2011 May; 37 Suppl 1():S42-9. PubMed ID: 21600333
[TBL] [Abstract][Full Text] [Related]
39. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study.
Gothelf D; Penniman L; Gu E; Eliez S; Reiss AL
Schizophr Res; 2007 Nov; 96(1-3):72-81. PubMed ID: 17804201
[TBL] [Abstract][Full Text] [Related]
40. Memory in intellectually matched groups of young participants with 22q11.2 deletion syndrome and those with schizophrenia.
Kravariti E; Jacobson C; Morris R; Frangou S; Murray RM; Tsakanikos E; Habel A; Shearer J
Res Dev Disabil; 2010; 31(3):864-8. PubMed ID: 20307954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
